Arctop
Israeli-American neuroscience software company translating brain signals into actionable insights for entertainment, wellness, and enterprise applications.
A reference guide to the companies, people, institutions, and technologies driving the brain-computer interface industry.
Israeli-American neuroscience software company translating brain signals into actionable insights for entertainment, wellness, and enterprise applications.
Pioneer of the Utah Array microelectrode technology with decades of implant experience, FDA-cleared MoveAgain device, and ongoing development of flexible electrode interfaces.
Chinese BCI unicorn developing non-invasive brain-computer interfaces and intelligent prosthetics, preparing for IPO at a reported $1.3 billion valuation.
German BCI company developing the Brain Interchange fully wireless closed-loop implant, advancing stroke rehabilitation through NIH-funded clinical trials.
Australian biotech company exploring biological computing through DishBrain, a hybrid system of cultured neurons on microelectrode arrays that demonstrated learned behavior in arcade games.
Chinese noninvasive ultrasound BCI startup founded by NeuroXess co-founder Phoenix Peng, pursuing focused ultrasound neuromodulation for chronic pain treatment.
Co-founded by Sam Altman and Alex Blania, backed by OpenAI, developing non-invasive ultrasound-based brain-computer interfaces with roots in Forest Neurotech.
Biotech company developing minimally invasive neurostimulation for major depressive disorder, targeting the 10x larger patient population compared to spinal cord injury alone.
Beijing-based BCI company incubated by the Chinese Institute for Brain Research (CIBR), developer of the Neucyber high-performance invasive BCI and the Beinao semi-invasive brain chip system.
Elon Musk's direct brain-computer interface company pursuing closed-loop neural recording and stimulation through minimally invasive robotic implantation and high-electrode-count chips.
Chinese government-backed BCI developer using polyimide mesh electrodes and fully implantable designs, competing globally with 54 human implants to date.
European medtech company developing spinal cord stimulation therapies that restore movement and function after spinal cord injury, integrated with BCI technology.
Open-source brain-computer interface hardware and software company providing accessible EEG headsets and the Galea multi-modal biosensing platform for research and development.
Austin-based BCI startup developing the Connexus system with 1600 channels for high-resolution neural recording, focused on speech restoration through rapid clinical trials.
Founded by ex-Neuralink neurosurgeon Benjamin Rapoport, developing the Layer 7 surface-array BCI with minimally invasive implantation and FDA clearance.
Shanghai-based developer of minimally invasive implantable brain-machine interfaces, holder of China's largest BCI funding round at $48 million.
Australian-founded endovascular BCI company developing the Stentrode for motor control without open brain surgery, backed by major philanthropies and tech partners.
Pioneering BCI researcher at University of Pittsburgh who led the development of motor BCIs enabling paralyzed individuals to control robotic arms with high degrees of freedom through brain signals.
First U.S. patient to receive Synchron's endovascular brain-computer interface implant, demonstrating the safety and efficacy of less-invasive BCI electrode placement.
Neuroscientist who discovered population vector coding, demonstrating how populations of motor cortex neurons encode movement direction and providing foundational theory for brain-computer interfaces.
Neurosurgeon and co-founder of Precision Neuroscience, designer of the Layer 7 cortical interface surface array, previously a key figure in Neuralink's neurosurgical program.
Chief Scientific Officer at Cortical Labs, leading development of biological computers powered by cultured neurons
Neuroscientist and engineer at Emory and Georgia Tech who developed LFADS (Latent Factor Analysis via Dynamical Systems), a foundational machine learning method for analyzing and decoding neural population dynamics.
Neurosurgeon and director of UC Davis Neuroprosthetics Lab, achieved 97% accuracy in BCI speech decoding and received 2025 Top Ten Clinical Research Achievement Award.
UCSF neurosurgeon and chair of neurological surgery, pioneered electrocorticography-based speech neuroprosthetics enabling real-time speech decoding from paralyzed patients.
Entrepreneur and founder of Neuralink, pursuing brain-computer interfaces as part of a broader vision of human-AI symbiosis and consciousness preservation.
Stanford neuroscientist and co-director of the Stanford Neural Prosthetics Translational Laboratory who achieved record-breaking speech BCI decoding speeds and accuracy.
EPFL neuroscientist who created the brain-spine digital bridge enabling paralyzed patients to walk again through thought-controlled spinal stimulation.
German psychiatrist and inventor of electroencephalography (EEG), who first recorded the electrical activity of the human brain in 1924.
Stanford neurosurgeon and co-director of the Stanford Neural Prosthetics Translational Laboratory who has performed numerous landmark BCI implant surgeries, including record-breaking speech BCIs.
Founding father of the modern BCI field, creator of BrainGate, and pioneer of the Utah Array-based intracortical brain-computer interface for human use.
Spanish neuroscientist who pioneered electrical brain stimulation experiments, demonstrating the ability to modify behavior through direct stimulation of the brain in the 1960s-70s.
University of Houston neuroengineer leading large-scale BCI clinical trial surveys and pioneering non-invasive brain-machine interfaces for mobility restoration.
Late Stanford neuroscientist whose laboratory pioneered high-performance BCI algorithms and neural decoding methods, posthumously honored as a foundational figure in the field.
Director of the BrainGate research consortium, Brown University professor, and pioneer of clinical brain-computer interface research whose work established the foundation for current commercial BCIs.
Founder and CEO of Paradromics, developing high-bandwidth brain-computer interfaces that record from individual neurons to restore communication for people with severe paralysis.
Brazilian neuroscientist and pioneer of multi-electrode neural recording, demonstrated monkey brain-controlled robotic arms, and initiated the Walk Again Project connecting brain signals to exoskeletons.
Neurotechnology thought leader, former AI executive at Intel and Databricks, and publisher of the influential Neurotechnology Substack covering BCI industry trends and funding.
Co-inventor of the Stentrode endovascular brain-computer interface and founding CTO of Synchron
Duke University law and philosophy professor, author of "The Battle for Your Brain," and leading voice on cognitive liberty, neuroethics, and the legal implications of neurotechnology.
Neuralink's first human patient, a quadriplegic who regained the ability to control a computer cursor with his mind through a brain-computer interface implant.
Pioneering neuroscientist who implanted the first long-term brain-computer interface electrode in a human patient in 1996, establishing the feasibility of chronic neural interfaces.
Serial BCI entrepreneur, co-founder of NeuroXess and founder of Gestala, driving China's noninvasive ultrasound brain-computer interface development.
Columbia University neurobiologist and founder of the NeuroRights Initiative, leading the global movement to protect mental privacy and cognitive liberty in the age of neurotechnology.
UC Davis neuroscientist and neuroengineer who developed speech BCIs achieving 97% accuracy and enabling people with ALS to speak in real-time.
Australian neurologist and founder of Synchron, pioneering the Stentrode endovascular brain-computer interface approach that eliminates open brain surgery.
Strategic futurist, keynote speaker, and author of Neuraleap (FastCompany Press, 2026) — exploring how brain-computer interfaces will transform commerce, society, and governance.
Multi-institutional research consortium pioneering clinical brain-computer interfaces, led by Leigh Hochberg, conducting ongoing human trials demonstrating functional motor and speech control.
United States defense research agency that has funded foundational BCI research programs over decades, directly enabling the technological basis for current commercial brain-computer interfaces.
United States Food and Drug Administration's regulatory framework for brain-computer interfaces, balancing innovation speed with patient safety through Breakthrough Device designation and investigational exemptions.
Swiss research institution founded by philanthropist Hansjorg Wyss, translating neuroscience discoveries into clinical applications including the ABILITY communication platform.
Subdural electrode grid recording technology positioned on the brain's surface, enabling high-resolution neural signal acquisition with lower surgical invasiveness than penetrating arrays.
Fully noninvasive scalp-based neural recording using surface electrodes, the oldest BCI approach with limited spatial resolution but zero surgical risk.
Emerging noninvasive neuroimaging approach using ultrasound to measure hemodynamic changes reflecting neural activity, pursued by Merge Labs and others for completely implant-free BCIs.
Synchron's endovascular electrode array delivered via catheter through blood vessels to the brain, enabling neural recording without open brain surgery.
The pioneering microelectrode array technology from University of Utah, establishing intracortical recording as the gold standard for high-signal-quality brain-computer interfaces.
Get the latest BCI news, breakthroughs, and market moves delivered to your inbox.
No spam. Unsubscribe anytime. We respect your privacy.